Insuring Psychedelics: The Missing Link

Insurance for the nascent psychedelics industry is a four-letter word. And where available, while business insurance is often purchased as part of licensing obligations, is it often treated as an oversight and later forgotten.

This webinar shares insider tips and tricks for making insurance a profit center. We will discuss the current state of the market for insuring psychedelic businesses, including types of insurance policies, “red flag” policy terms, best practices for applications, and more.

Presented by: Jodi Green, Counsel, Feldman Legal Advisors

After protecting insurance companies from up to billion-dollar liabilities in her early career, Jodi Green now helps forward-thinking organizations mitigate risks, with a focus on startups and companies operating in highly-regulated industries, such as cannabis and psychedelics. Jodi is licensed to practice law in California and Illinois and assists clients with a wide range of legal needs, including corporate governance; complex contracts; regulatory compliance; and insurance coverage and risk management. She also provides fractional general counsel and risk management services to growth-stage entities.

Vital 2023: Informational Session and Q&A

Are you considering attending our upcoming 2023-2024 cohort of Vital, our 12-month psychedelic training certificate program?

Do you have questions before applying?

Are you looking to level up your offerings in the expanding field of psychedelic-assisted support and want to know how to get there?

We will be hosting live Q&A’s to answer all of your questions to help you feel prepared to sign up for our upcoming course.

Thursday Feb 2nd, 12-1 pm EST

Tuesday Feb 7th, 2023 12pm – 1pm EST

Thursday Feb 16th, 2023 12pm – 1pm EST

Thursday Feb 23rd, 2023 12pm – 1pm EST

Monday Feb 27th, 2023 3pm – 4pm EST

Webinar: Psychedelic Integration and Depth Relational Process

Integration as a word is being applied to a wide range of practices and means different things in different settings. How can we understand the process of integration from a Depth Relational Process perspective which highlights depth perspectives – like the Jungian or attachment lens -, relational unfolding and depth of processing? And how can we match integration set with integration setting from a theoretically pluralistic perspective to meet the needs of people post experience at an appropriate and adequate level?

Depth Relational Process is a model we have co-developed with Dr. Tim Read in support of working with the deep psyche as well as expanded states. In this talk we will consider the main elements of working in this way alongside some clinical material to bring some of these ideas into the realm of practice.

Maria Papaspyrou is a senior accredited psychotherapist, working in private practice in Brighton, UK. Her core trainings have been in integrative relational psychotherapy, systemic family constellations and supervision. She has had a long-term interest in the healing potential of expanded states and her clinical practice focuses on psychedelic integration and working as a supervisor for individuals and organisations in this field.

She has co-edited “Psychedelic Mysteries of the Feminine” with Chiara Baldini and David Luke and “Psychedelics & Psychotherapy: The Healing Potential of Expanded States” with Dr Tim Read. With Tim they have co-founded and co-direct the Institute of Psychedelic Therapy (IPT) where they have co- developed and teach a 2-year professional training on Psychedelic Assisted Therapy through their model, Depth Relational Process.

You can find out more about her work at towardswholeness.co.uk.

Webinar – Death, Dying, and Psychedelics

Psychedelics open us to the prospect of death as part of our common humanity and consciousness. Research from NYU, Johns Hopkins and UCLA have consistently shown that psilocybin, not just reduced the anxiety and depression associated with the fear of dying in cancer patients, but it also brought feelings of unity and peace and acceptance to death and dying.

This panel will bring together the Founder of the first-of-its-kind end-of-life psilocybin retreat and training, the End-of-Life Doula who led the programs’ development, a psychedelic trained psychotherapist with 30 years’ experience as a hospice social worker and cancer survivor who participated in an MDMA study for individuals with life-threatening illnesses, and a Psychedelics Today colleague who was transformed through psychedelics after the death of her father.

Join them in an engaging panel discussion to talk about the death and dying process, the role of an End-of-Life Doula in this process, how and why psychedelics are powerful sources for healing in those with terminal diagnoses, and how you can begin to shift your thinking about death and dying. They each will share their personal stories with psychedelics and death which are moving testimonials to the potency of psychedelics for this, the most important, part of one’s life journey.

Please note that an attendee report (names, email addresses) is shared with the partner.

Panelists:

Christina Ingenito – LCSW, Psychedelic-Assisted Psychotherapist, Clinical Director at Diaspora Psychedelic Society

Monica Miller – Event Manager at Psychedelics Today

Catherine Durkin Robinson – Death Doula and Educator at Anitya Doula Services

Host:

Christine Caldwell – Manager, End-of-Life Programs at Diaspora Psychedelic Society

Eyes on Oregon: Special Edition

On November 1, the Oregon Health Authority published its proposed final rules for the Measure 109 psilocybin services program. OHA also has given “last call” for public comment and scheduled three public comment hearings November 15-17.

Join attorney and activist Jon Dennis in a conversation moderated by Professor Pilar Hernandez Wolf about the proposed psilocybin rules and ways to help educate OHA around issues of community concern.

Webinar – The Dark Side of Psychedelic Therapies

Join us for a presentation with Cathy Harris, LCSW, who will be sharing about her lived experience in a cult, which ultimately led her toward helping others find self-compassion and joy in life.

After her experience, Cathy has been learning and working over the last 25 years to facilitate healing in many settings: military and civilian substance abuse treatment (adults and teens), in-home therapy, crisis center, mobile crisis, inpatient trauma treatment, outpatient group treatment and private practice.

Her work is rooted in Trauma-Informed thinking and she finds fulfillment in sharing this perspective with a variety of professionals. She currently works with veterans, active duty and ex-cult members via private practice.

Cathy’s presentation will cover:

• Defining and understanding what a cult is, using Lifton’s 8 Critera.
• The physical, mental, and emotional effects of cults and cult behavior.
• Why psychedelic therapy/work is vulnerable to cults and cult behavior.
• The role of Vicarious Trauma in development and healing.

Free Webinar – Nue Life: Empowering Patients with At-Home Ketamine Therapy

Join us for an open dialogue with several game-changers from Nue Life who will discuss their treatment, findings, and a call for mainstream adoption of this method of care.

Many in the United States are benefitting from ketamine treatment, reporting that major symptoms of depression are reduced after just a few doses in a clinical setting. This medicine, when used with intention and care, can bring a new level of mental wellness to one’s life.

However, psychedelics like ketamine have a long history of stigma, resulting in reluctance from prescribers to adopt this type of treatment. The lack of ketamine prescribers presents a bottleneck to the mainstreaming of psychedelic treatment within the mental health infrastructure.

NueLife—a team of dedicated physicians, expert technologists, and compassionate clinicians—delivers responsive, personalized ketamine therapy in the comfort of their clients’ homes. Research shows that of their 650 patients with treatment-resistant depression and anxiety, approximately 2/3rds saw over a 50% reduction in symptoms after just six ketamine sessions.

Panelists:

Lauren Marchefka – Board-certified family nurse practitioner and member of the senior medical team at Nue Life.

Lynn-Marie Morski – President of the Psychedelic Medicine Association, host of the Psychedelic Medicine Podcast, and Medical Director for Nue Life Health.

Ben Medrano – Medical Director of Nue Life Medical Group. Additionally, Ben works in patient care as Medical Director of Field Trip NYC and DC clinics while providing direct care within his private practice.

Host:

David Drapkin – The Director of Operations and Strategic Growth at Psychedelics Today. Additionally, he is a licensed clinical social worker and seasoned mental health and addiction practitioner.

Free Webinar — Psychedelic Autism: A Brief Intro and Q&A with Aaron Orsini

During this webinar, Aaron will provide a very brief introduction to the intersection of psychedelics & autism. He and the audience will then dive into an open Q&A with space for individuals to briefly share about their own experiences, if they feel called to do so.

Aaron Paul Orsini is an autistic psychedelic author, researcher, educator & community organizer. In addition to publishing three books on his area of focus — Autism On Acid (2019), Autistic Psychedelic (2021), & Intro To Psychedelic Autism (2022) — Aaron also serves as the Outreach & Education Director of the AutisticPsychedelic.com Community (APC), a collaborative online org offering resource libraries, public chat forums, weekly peer support Zoom meetings, & online education courses for autistic adults & the therapists, guides, clinicians & family members who seek to support them through psychedelic-informed care.

Aaron also serves as an advisory co-author partner to psychedelic autism researchers at University College London, where he & his fellow researchers are soon to publish the world’s first peer-reviewed survey examining outcomes in naturalistic psychedelic use among autistic adults. The survey is scheduled to be released via open access early next year.

For more information about the APC, please visit AutisticPsychedelic.com, & for more information on other initiatives that Aaron is involved in, please visit: http://linktr.ee/aaronorsini

Please note that registrations (names, email addresses) are shared with the webinar collaborator.

Free Webinar — Psychedelics for Veterans: The Battle for a Better Standard of Care

When it comes to patient populations, veterans are among the most challenging to treat. Many return from service with debilitating conditions, including PTSD, treatment resistant depression, traumatic brain injury and chronic pain.

The costs – both financial and human – of military service are extreme. Recent studies suggest that between 2001 and 2050, the total costs of caring for veterans of the post-9/11 wars will reach between $2.2 and $2.5 trillion. It is estimated that on average, 44 veterans die in the United States every day from suicide.

Can psychedelics promise new hope to veterans suffering in sub-standard models of care? How can psychedelics be used to create a better standard of care for veterans and their families?

Join us in discussion with three North American veterans (Arron Victory, Apex Labs; Jesse Gould, Heroic Hearts; and Justin LaPree, Heroic Path to Light) on the eve of Remembrance Day (Canada) and Veterans Day (U.S.) on topics including:

• How psychedelics are currently being used by veteran populations, both above and underground
• The current standard of care for veterans post-service, the strengths of the current system and where it falls short
• Grassroots community efforts to support veterans and first responders in North America
• How biotech is working to create alternate psychedelic treatment options for veteran populations
• Ongoing and upcoming clinical trials to study the effects of psychedelics on veterans
• How governments are responding to calls for psychedelic access for veterans
• Successes veterans and their families are finding in psychedelic therapies

Free Webinar — Starting a KAP Practice: Best Practices from Journey Clinical

A growing number of mental health professionals are enrolling in training programs in psychedelic-assisted psychotherapy, but don’t know know to implement PAP in their practice. Join cofounder and CEO Jonathan Sabbagh to learn more about how Journey Clinical enables licensed psychotherapists to deliver PAP in your own practice, starting with Ketamine-Assisted Psychotherapy. Jonathan will explain the Journey Clinical collaborative care model and technology platform, and share how their member psychotherapists successfully deliver KAP in their practice as an adjunct to therapy.

Jonathan is the Co-Founder and CEO of Journey Clinical, the leading telehealth platform expanding access to Psychedelic-Assisted Psychotherapy. A serial entrepreneur, Jonathan built his career in finance, spending over two decades working for hedge funds and building businesses in Switzerland and NYC. After receiving a difficult diagnosis of PTSD and extreme burnout, Jonathan left the world of finance to focus on his mental health, during which he personally experienced the transformative benefits of plant medicine and Ketamine-Assisted Psychotherapy (KAP).

Ultimately, Jonathan’s personal and professional journey motivated him to found Journey Clinical in 2020, the #1 platform in the US that enables licensed mental health professionals to deliver KAP at scale. Learn more at www.JourneyClinical.com.

Please note that registrations (names, email addresses) are shared with the webinar collaborator.

Free Webinar — Traditional and Modern Perspectives on Healing

Join us for “Traditional and Modern Perspectives on Healing,” part two of a two-part series in collaboration with the Indigenous Medicine Conservation Fund (IMC Fund). The IMC Fund was co-created for the sovereign protection and regeneration of the medicines, ecologies & traditional knowledge Indigenous communities have honored for thousands of years.

In this webinar, we will be looking at the importance of respecting traditional Indigenous cultures and practices. This panel brings together professionals with both traditional and modern training to discuss these medicines and how they are being worked with at this time by different groups and in different demographics, and to learn together in an exchange between equals. Building on part one of the series, panelists will discuss the differences between appreciation and appropriation, and share their experience in the field and on the ground.

Please note that registrations (names, email addresses) are shared with the webinar collaborator.